Imatinib mesylate in the treatment of newly diagnosed or refractory /resistant c-kit positive AML. Results of an italian multicentric phase II study.
Abstract
Publication Date:
2005
CRIS type:
4.2 Abstract in Atti di convegno
List of contributors:
Malagola, Michele; Piccaluga, Pp; Martinelli, G; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottaviani, E; Candoni, A; Fanin, R; Cilloni, D; Gottardi, E; Saglio, G; Bocchia, M; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M.
Book title:
40° Congresso della Società Italiana di Ematologia
Published in: